PEAK6 Investments’s CONMED CNMD Stock Holding History

PEAK6 Investments’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$275K	Buy	+3,825	New	+$270K	﹤0.01%	2630
2023 Q3	–	Sell	-1,038	Closed	-$119K	–	4114
2023 Q2	$141K	Buy	+1,038	New	+$127K	﹤0.01%	3077
2023 Q1	–	Sell	-12,769	Closed	-$1.23M	–	4359
2022 Q4	$1.13M	Buy	+12,769	New	+$1.06M	0.01%	1820
2022 Q3	–	Sell	-8,259	Closed	-$779K	–	5105
2022 Q2	$832K	Buy	8,259 +4,895	+146%	+$587K	﹤0.01%	3270
2022 Q1	$500K	Sell	3,364 -1,760	-34%	-$246K	﹤0.01%	3133
2021 Q4	$726K	Buy	5,124 +1,118	+28%	+$158K	﹤0.01%	2869
2021 Q3	$524K	Buy	+4,006	New	+$524K	﹤0.01%	3205
2021 Q1	–	Sell	-8,589	Closed	-$1.03M	–	4905
2020 Q4	$962K	Buy	+8,589	New	+$813K	﹤0.01%	2522
2020 Q3	–	Sell	-1,965	Closed	-$160K	–	4432
2020 Q2	$141K	Sell	1,965 -14,931	-88%	-$1.04M	﹤0.01%	3636
2020 Q1	$968K	Buy	+16,896	New	+$1.56M	0.01%	1558
2019 Q1	–	Sell	-1,309	Closed	-$95.1K	–	3917
2018 Q4	$84K	Buy	+1,309	New	+$89.6K	﹤0.01%	3465

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

PEAK6 Investments's CNMD Position: Q3 2024 in Review

PEAK6 Investments opened a new position in CONMED (CNMD) in Q3 2024: 3,825 shares worth $275K. The stake represents ﹤0.01% of the portfolio and ranks #2630 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in CNMD as recently as Q2 2023.

PEAK6 Investments first reported a position in CNMD in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.13M in Q4 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q3 2024.

PEAK6 Investments held 3,825 shares of CONMED worth $275K as of Q3 2024.
CONMED was a new PEAK6 Investments position in Q3 2024.
CONMED made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2630 holding.
PEAK6 Investments first reported a position in CONMED in Q4 2018 and has held it in 11 quarters since.
PEAK6 Investments's CONMED position peaked at $1.13M in Q4 2022.
290 funds tracked by Wall St. Rank held CONMED as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.